Advertisement

Topics

MorphoSys AG, Company Profile

21:48 EDT 24th June 2018 | BioPortfolio

MorphoSys AG, located in Martinsried/Munich, is one of the world's leading biotechnology companies focusing on fully human antibodies. With its unique technologies, MorphoSys is developing the next generation of antibodies, which can be used to treat diseases and for research and diagnostics purposes. Numerous partnerships have already been entered into with well-known companies from the pharmaceutical and biotechnology sectors, such as Bayer, Boehringer Ingelheim, Centocor/Johnson & Johnson, Daiichi Sankyo, Novartis, Pfizer, Roche and Schering.The Company, founded in 1992, possesses the unique HuCAL technology (the Human Combinatorial Antibody Library). This library comprises more than ten billion different, fully human antibodies. HuCAL is a very powerful technology, which allows rapid and automated production of high-affinity antibodies. The most important feature of the library is its capability of optimizing fully human antibodies to meet predefined specifications.

Location

Lena-Christ-Strasse 48
Martinsried
Planegg
82152
Germany

Contact

Phone: 49 (0)89 / 899 27-0
Fax: 49 (0)89 / 899 27-222
Email: investors@morphosys.com


News Articles [265 Associated News Articles listed on BioPortfolio]

Morphosys: Positives Feedback

Die Analysten der Commerzbank erneuern die Kaufempfehlung für die Aktien von Morphosys. Das Kursziel wird ebenso bestätigt. Es liegt für die Papiere von Morphosys bei 98,00 Euro. Die Gesellschaft h...

Morphosys: Große Spanne bei den Kurszielen

Nach den Zahlen von Morphosys gibt es eine Reihe von Analystenstimmen. So bestätigen die Experten von Goldman Sachs das Rating "neutral" für die Papiere von Morphosys. Das Kursziel sehen die Amerik....

MorphoSys: JPMorgan-Analyst sieht rosarote Zukunft!

Lieber Leser, zu den größeren Gewinnern im TecDAX zählte zum Wochenausklang am Freitag die Aktie des Biotechnologieunternehmens MorphoSys aus Martinsried bei München. Aus meiner Sicht ist MorphoSy...

MorphoSys: Kapitalerhöhung vor US-Start

Das Biotech-Unternehmen MorphoSys erhöht für die geplante Aktienplatzierung an der US-Börse das Grundkapital. Mit Zustimmung des Aufsichtsrats habe man beschlossen, das Grundkapital der MorphoSys A...

Morphosys: Aktie erhält neues Kursziel

Die Analysten von Independent Research bestätigen die Kaufempfehlung für die Aktien von Morphosys. Das Kursziel für die Papiere von Morphosys sahen die Experten bisher bei 93,00 Euro. In der heutig...

Morphosys: Kursziel geht weiter nach oben

Die Analysten von Oddo BHF bestätigen die Kaufempfehlung für die Aktien von Morphosys. Das Kursziel für die Papiere von Morphosys sahen die Experten bisher bei 93,00 Euro. In der heutigen Studie de...

MorphoSys: Kursziel von 100,00 Euro erreicht, aber die Risiken nehmen zu!

Einer meiner langfristigen Favoriten am deutschen Aktienmarkt ist schon seit längerer Zeit das Papier des Biotechunternehmens MorphoSys. Ja, ich halte MorphoSys aktuell sogar für die beste deutsche....

MorphoSys AG: MorphoSys Announces Approval of Tremfya(R) (Guselkumab) in South Korea

PLANEGG and MUNICH, GERMANY / ACCESSWIRE / April 26, 2018 / MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX; OTC PINK: MPSYY; NASDAQ: MOR) announced today that an affiliate of its licensee, ...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [5 Associated Companies listed on BioPortfolio]

MorphoSys GmbH

MorphoSys AG, located in Martinsried/Munich, is one of the world's leading biotechnology companies focusing on fully human antibodies. With its unique technologies, MorphoSys is developing the next ge...

Biogenesis Ltd

Biogenesis is a recognized leader in the supply of monoclonal and polyclonal antibodies and custom manufacturing services to IVD manufacturers, pharmaceutical companies and life science researchers ar...

MorphoSys AG,

MorphoSys AG, located in Martinsried/Munich, is one of the world's leading biotechnology companies focusing on fully human antibodies. With its unique technologies, MorphoSys is developing the next ge...

MorphoSys AG

MorphoSys AG, located in Martinsried/Munich, is one of the world's leading biotechnology companies focusing on fully human antibodies. With its unique technologies, MorphoSys is developing the next ge...

Antibodies by Design

Antibodies by Design uses proven MorphoSys recombinant antibody technology to provide high quality monoclonal antibodies to its customers in record time. The HuCAL GOLD® library contains over 15 bill...

More Information about "MorphoSys AG," on BioPortfolio

We have published hundreds of MorphoSys AG, news stories on BioPortfolio along with dozens of MorphoSys AG, Clinical Trials and PubMed Articles about MorphoSys AG, for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of MorphoSys AG, Companies in our database. You can also find out about relevant MorphoSys AG, Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Corporate Database Quicklinks



Searches Linking to this Company Record